Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study

Author(s):  Kumaravelrajan Rajagopal, Rockiyasamy Kishore metha, Venkatesan Suba, Thiraviam Purushoth Prabhu

Issue:  Jan/Feb 2025 - Volume 29, Number 1
View All Articles in Issue

Page(s):  14-21

K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 1
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 2
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 3
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 4
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 5
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 6
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 7
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study Page 8

Download in electronic PDF format for $75

Abstract:  This study investigates the potential of using kappa-carrageenan and hydroxypropylated tapioca starch as alternatives to traditional gelatin capsules in pharmaceutical applications. Nine formulations are developed and optimized based on viscosity, appearance, and loss on drying. The process involves a rotary die method for encapsulation, followed by characterization including SEM analysis, moisture content, and stability assessment. The optimized formulation (F8) demonstrates clear description, appropriate viscosity (11035 cps), and acceptable loss on drying (33.5%). Physical characterization reveals consistent capsule dimensions and moisture content within acceptable ranges. Disintegration and drug release studies indicate promising performance, with capsules dissolving within 15 minutes and achieving 99.23% drug release in 60 minutes. Stability testing confirms the suitability of the optimized formulations for pharmaceutical use.

Related Categories: DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version